Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

145
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
145
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

104
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
104
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

1.8K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.2K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

137
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
137
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative learning of individualized treatment rules from multiple studies with partially overlapping treatments.

Biometrics·2026
Same author

DYNAMIC CLASSIFICATION OF LATENT DISEASE PROGRESSION WITH AUXILIARY SURROGATE LABELS.

The annals of applied statistics·2026
Same author

Learning optimal early decision treatment rules with multi-domain intermediate outcomes.

Biometrics·2026
Same author

Computationally efficient methods for estimating phenome-wide coheritability of multi-type phenotypes using biobank data.

Communications biology·2025
Same author

Simultaneous Feature Selection for Optimal Dynamic Treatment Regimens.

Statistics in medicine·2025
Same author

A hierarchical random effects state-space model for modeling brain activities from electroencephalogram data.

Biometrics·2024

Related Experiment Video

Updated: Oct 11, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K

Conditional Gaussian graphical model for estimating personalized disease symptom networks.

Shanghong Xie1,2, Erin McDonnell2, Yuanjia Wang2,3

  • 1School of Statistics and Center of Statistical Research, Southwestern University of Finance and Economics, Chengdu, China.

Statistics in Medicine
|December 6, 2021
PubMed
Summary

This study introduces personalized symptom networks using a novel graphical model. The findings reveal domain-specific symptom interactions and identify key brain imaging biomarkers in Huntington's disease.

Keywords:
Huntington's diseasegraphical modelsymptom network

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Related Experiment Videos

Last Updated: Oct 11, 2025

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.8K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Area of Science:

  • Computational biology
  • Network medicine
  • Biostatistics

Background:

  • Symptom co-occurrence suggests underlying system interactions.
  • Individual risk factors (genetics, age) influence these symptom systems.
  • Understanding heterogeneous symptom networks is crucial for personalized medicine.

Purpose of the Study:

  • To develop a covariate-dependent conditional Gaussian graphical model for personalized symptom networks.
  • To capture individual and subgroup heterogeneity in symptom interactions.
  • To identify brain imaging biomarkers associated with symptom network connections in Huntington's disease.

Main Methods:

  • Developed a novel covariate-dependent conditional Gaussian graphical model.
  • Modeled network connection strengths as a function of covariates.
  • Applied the model to Huntington's disease natural history study data.

Main Results:

  • Symptoms within the same clinical domain (motor, cognitive, psychiatric) interact more frequently than across domains.
  • The psychiatric symptom subnetwork demonstrated the highest density.
  • Identified significant associations between brain imaging biomarkers and symptom network connections.

Conclusions:

  • Personalized symptom networks can be effectively modeled using covariate-dependent graphical models.
  • Symptom interactions exhibit domain specificity, with psychiatric symptoms forming a dense network.
  • Brain imaging biomarkers are linked to specific symptom network connections, offering insights into disease mechanisms.